Fool.com
The World's Greatest Investing Community
Results 1 - 10 of 515 : 1 2 3 4 5 6 7 8 9 Next
After Rising 500%, What Did You Expect?
A nice licensing deal, but the stock was too high to begin with.
Now is a particularly promising time to launch your investments.
Bonds: Out. Stocks: Out. What's Left?
Resolving this conundrum can protect your wealth.
Drug companies shape up, and it shows in their margins.
Eli Lilly adds another approval onto Cymbalta.
The Real Problem With the Public Health-Care Plan
It's the morphing part that should scare you.
This Big Winner Has Hit Its Prime
There are still a few ways to benefit from Primecap's expertise.
A Big Upgrade for Amylin Pharmaceuticals
This bullish call comes from more than just one analyst.
Check out these income stocks for steady returns.
Do Good Without Being a Corporate Hotshot
You don't need to be big to do good.
Legal Information © 1995 - 2009 The Motley Fool. All rights reserved.
Market Data provided by 
Terms & Conditions
RSS Headlines
Fool UK